Sen. Kirk Cullimore (R)

SB 248 (Strengthening Utah’s Psychotherapeutic Therapy Pilot Program)

Libertas Institute supports this bill.

SB 248This bill ensures that Utah’s medicinal psilocybin and MDMA pilot program can move forward by allowing qualified healthcare providers to participate after the initial healthcare systems declined to do so.

Libertas supports this bill. Patients suffering from PTSD, depression, and other mental health conditions deserve access to these promising treatments. SB 248 strengthens the pilot program by ensuring experienced providers can step in, allowing patients to receive care in a controlled, supervised setting.